Human enteroviruses (EVs) are the major cause of a variety of acute and chronic illnesses. Virus isolation and neutralization tests are usually done to identify the causative virus, but these tests are labor intensive, time consuming, and sometimes require suckling mice from which certain viruses have been isolated. This study investigated a rapid and reliable method based on reverse-transcription polymerase chain reaction and phylogenetic analysis. The phylogenetic tree constructed by neighbor-joining on the basis of the VP4 sequence from 66 prototypes grouped all human EVs into 5 distinct clusters. These clusters correspond closely to the 5 newly designated species-human EV A-D and poliovirus. The VP4 sequences of 89 isolates from 26 serotypes obtained over .30 years plus those of 66 prototype strains were analyzed. Each isolate formed a monophyletic cluster along with its respective prototype strain, allowing for serotype identification (with the exception of E-8). VP4-based classification appears to be an effective tool for the molecular epidemiology study of EVs.
Human enteroviruses (EVs) in the genus Enterovirus of the family Picornaviridae form a group of viruses with numerous serotypes. EVs infect billions of people worldwide and cause clinical manifestations such as poliomyelitis; aseptic meningitis; myocarditis; hand, foot, and mouth disease (HFMD); herpangina; acute hemorrhagic conjunctivitis (AHC); and other acute and chronic illnesses [1] .
In Japan, 60,000 EVs have been isolated from persons with meningitis, HFMD, herpangina, and the common cold during the last 2 decades [2] . EVs initially were subgrouped into poliovirus (PV), coxsackievirus (CV)-A, CV-B, and echovirus (E) on the basis of their pathogeneses in humans and in experimental animals [1] . Later, 4 serotypes were discovered and were designated EV-68-EV-71 [3] . Through serotype-specific antisera, EVs were further classified into 64 serotypes (e.g., PV-1-PV3, CV-A1-CV-A24, CV-B1-CV-B6, E-1-E-33, and EV-68-EV-71) [1] . CV-A23, E-8, E-10, E-28, and E-34 are missing because they appeared to be the same as E-9, E-1, reovirus type 1, human rhinovirus 1A, and CV-A24, respectively [1] . In this classification, E-22 and E-23 were removed from the genus Enterovirus and classified in a new genus, Parechovirus, where they are designated human parechoviruses 1 and 2 [4] [5] [6] . In 1999, reclassification of EVs on the basis of the nucleotide and deduced amino acid sequences was approved by the International Committee on Taxonomy of Viruses (ICTV), after which the 64 EV serotypes in the genus Enterovirus were grouped into 5 species [7] .
Virus isolation followed by a neutralization test is usually done for the serotyping of EVs [1] . However, these procedures are complicated and time consuming. In addition, some EVs are refractory to isolation with cultured cells. At present, amplification of the genome by reverse-transcription (RT) polymerase chain reaction (PCR), determination of the nucleotide sequences, and phylogenetic analysis are standardized techniques for both classification and identification of EVs [4, [8] [9] [10] . VP1 carries major neutralization epitopes among the capsid proteins and is likely to be the best region for a phylogeny-based classification [11] [12] [13] [14] . However, the major problem with VP1 for amplification is that it is quite difficult to design common primers for EVs in either VP1 or the flanking region of the genome. This difficulty is due to much higher numbers of nucleotide sequence variations among different serotypes here than in other regions [13] . Yet, when available complete nucleotide sequences of EVs were compared, the 5 0 nontranslated region (NTR) and capsid protein VP2 appeared to be well conserved among EVs [15, 16] . Therefore, primers targeted to these regions were selected, and the entire VP4 encoded between these 2 regions was used to determine the genetic relationship.
In this investigation, we determined the VP4 nucleotide sequences with 46 prototype strains, which have not been available from GenBank, and we completed the determination of VP4 sequences of all 66 prototype strains, including a variant of CV-A24 (EH24/70 strain) and a strain of E-1 (E-8, Bryson strain). The VP4 database thus constructed was used for a phylogeny-based identification of EV isolates from patients with aseptic meningitis, HFMD, herpangina, and AHC, respectively.
Materials and Methods
Viruses. We obtained 66 prototype strains of human EVs from the American Type Culture Collection or the Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan (table 1) . These viruses were used directly for RNA extraction without further propagation. In total, 76 field isolates-including 19 isolates of a variant of CV-A24 (CV -A24v) obtained between 1970  and 1988, 14 EV-70 isolates collected between 1970 and 1981  from patients with AHC (table 2) , 38 isolates of 14 serotypes from patients with aseptic meningitis, HFMD, or herpangina, and 5 isolates of 5 serotypes purchased from the American Type Culture Collection-were propagated in either LLC-MK2 or HeLa cells (table 3) . These isolates were identified by a neutralization test with type-specific antisera purchased from Denka Seiken.
RNA extraction and RT-PCR. Viral RNA was extracted from 100 mL of virus solution by use of the Sumitest R kit (Sumitomo Metal Industries), according to the manufacturer's instructions. The RNA was dissolved with 10 mL of RNase-free distilled water containing 40 U of ribonuclease inhibitor (RNasin; Promega) and 50 pmol of a reverse primer, OL68-1 (nt 1178-1197, 5 0 -GGTAA(C/ T)TTCCACCACCA (A/T/G/C)CC-3 0 ) [16] . The positions of the primers for RT-PCR were numbered according to the complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain [17] . The RNA was subjected to heat denaturation for 15 s at 100 C followed by snap cooling in an ice-water bath. To each RNA sample, we added 10 mL of a reaction mixture containing 1£ Taq buffer (10 mM Tris-HCl [pH 8.3], 1.5 mM MgCl 2 , 50 mM KCl, and 0.001% gelatin), 200 U of Moloney murine leukemia virus reverse transcriptase (Life Technologies), 2.5 mM dNTPs, and 40 U of RNasin (Promega).
cDNA synthesis was performed for 1 h at 37 C. In total, 5 mL of the cDNA reaction mixture was added to 45 mL of 1£ Taq buffer containing 12.5 pmol of a forward primer, MD91 (nt 444-468, 5 0 -CCTCCGGCCCCTGAATGCGGCTAAT-3 0 ) [18, 19] , and 2.5 U of Taq DNA polymerase (Roche Diagnostic Systems). After an 
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Tompkins AB061444 initial denaturation at 94 C for 5 min, 40 cycles of amplification were done by using the GeneAmp PCR System 9600 (PE-Applied Biosystems). Each cycle consisted of denaturation at 95 C for 30 s, primer annealing at 55 C for 30 s, and an extension reaction at 72 C for 1 min followed by a final extension at 72 C for 7 min. The PCR products were separated in 1% agarose gel and purified with a QIA quick-gel extraction kit (Qiagen). The nucleotide sequence was determined with a 373A DNA auto sequencer (PEApplied Biosystems) with fluorescent dideoxy chain terminators (PE-Applied Biosystems) and MD91 and OL68 primers. An internal forward primer for the sequencing, EVP4 (nt 541-560, 5
0 -CTACT-TTGGGTGTCCGTGTT-3 0 ), was designed on the basis of the nucleotide sequence of the oligo probe, as described elsewhere [18] .
Phylogenetic analysis. The VP4 nucleotide sequences of 46 prototype strains not available from GenBank (CV-A1, CV-A3, CV-A5, CV-A6, CV-A8-CV-A15, CV-A17-CV-A22, CV-A24, CV-B1, CV-B5, CV-B6, E-2-E-7, E-13-E-15, E-17-E-21, E-24, E-25, E-27, E-30, E-31-E-33, EV-68, and EV-69) were determined in this study (table 1) . In total, 89 sequences from 26 serotypes, including 76 sequences from the field isolates and 13 sequences from 8 serotypes (CV-A21, CV-B3, CV-B4, E-6, EV-71, PV-1, PV-2, and PV-3) available from GenBank (table 3) were determined and used for phylogeny-based identifications. We analyzed 155 VP4 sequences by using SINCA software (Fujitsu). We estimated the evolutionary distances by the Kimura two-parameter method [20] and constructed unrooted phylogenetic trees by the neighbor-joining method [21] . Bootstrap analyses were performed by 1000 resamplings of the data sets. Bootstrap values >70% were considered to be statistically significant for the grouping [22] .
Nucleotide sequence accession numbers. The GenBank accession numbers of the nucleotide sequences in this study are AB053277-AB053291, AB061489-AB61502, AB61504-AB061513, AB061515-AB061517, AB053966-AB053998, and AB061472.
Results
Amplification of the 66 prototype strains. Comparison of the nucleotide sequences of the EV genome demonstrated that several short stretches (19-23 bases) in the 5 0 NTR are highly conserved among EVs [15] , and MD91, a 20-base stretch in the 5 0 NTR, was selected for a forward primer. A reverse primer, OL68-1, was designed on the basis of 3 tryptophan residues conserved in VP2 [16] . These primers allowed for amplification of 650 bp of the genome encoding a 3 0 one-third of 5 0 NTR, the entire VP4, and a 5 0 one-third of VP2 of 66 prototype strains (data not shown). RT-PCR with MD91 and OL68-1 primers was specific to EVs. There was no cross-amplification with a variety of heterologous viruses, including influenza, mumps, measles, herpes simplex, and cytomegalovirus (data not shown). Amplification of the genome of enteric viruses, including Norwalklike viruses, rotaviruses, and enteric adenoviruses, also did not occur (data not shown). The sensitivity of the RT-PCR, as determined by a 650-bp band after the staining, appeared to be 0.1-1.0 TCID 50 /mL when 10-fold serial dilutions of the prototype strains of CV-A24v, E-18, E-30, EV-70, and EV-71 were tested (data not shown). These results indicate that the primer sets were specific to EVs and capable of amplifying all prototype EV strains.
Phylogenetic analysis of prototype strains. To date, 20 VP4 sequences of the prototype strains are available from GenBank. To obtain the complete set of VP4 nucleotide sequences, the nucleotide sequences of the remaining 46 prototype strains were determined as described in Materials and Methods (table 1 ). An alignment of the VP4 nucleotide sequences from 66 prototype EV strains, including a variant of CV-A24 (EH24/70) and E-8 (Bryson), was done with the SINCA genetic software program. All prototype strains appeared to contain 207 bases for VP4, and neither deletion nor insertion occurred among them.
To assess the genetic relationships among EVs, a phylogenetic tree based on VP4 nucleotide sequences was constructed. As shown in figure 1 , the EVs were segregated into 5 major clus- Figure 1 . Phylogenetic analysis of enterovirus (EV) prototype strains. Nucleotide sequences of VP4 (207 bases) from 66 prototype strains were analyzed by the neighbor-joining method. Nos. at nodes are percentages of 1000 bootstrap pseudoreplicates containing the cluster distal to the node. Minimum and maximum nucleotide identities between the prototype strains in each cluster are shown under cluster names. CV, coxsackievirus; E, echovirus; PV, poliovirus. Figure 2 . Phylogenetic analyses of clinical isolates from patients with acute hemorrhagic conjunctivitis. Nucleotide sequences of VP4 of the isolates were determined and analyzed along with prototype strains by the neighbor-joining method. Nos. at nodes are percentage of 1000 bootstrap pseudoreplicates containing the cluster distal to the node. A, Nineteen CV-A24v isolates forming cluster C and CV-A24v prototype strain EH24/70 (*). B, Fourteen EV-70 isolates forming cluster D with EV-70 prototype strain J670/71 (*). CV, coxsackievirus; EV, enterovirus.
ters: A-D and poliovirus. Each cluster corresponded well to the 5 newly designated human EV species: A-D and poliovirus [7] . The genetic relationships of the 66 prototype strains within and between clusters were further analyzed by a one-by-one comparison. The nucleotide identity among the 66 prototypes was 50.7%-86.0% (mean, 66.7%). In each cluster, the nucleotide identity ranged from 61.8% (CV-A10 and EV-71; CV-A14 and EV-71) to 75.8% (between CV-A5 and CV-A12) in cluster A; from 64.3% (between E-2 and E-12) to 86.0% (between E-20 and E-25) in cluster B; and from 69.1% (between CV-A13 and CV-A21; CV-A18 and CV-A19) to 86.0% (between CV-A17 and CV-A24v) in cluster C. The nucleotide identity score between EV-68 and EV-70 was 76.8%; scores among polioviruses were 74.9%-77.3%. These results indicate that the phylogenetic analysis with VP4 nucleotide sequences is capable of distinguishing each of the 66 prototype strains.
Amplification and identification of clinical AHC isolates. To evaluate the reliability of the phylogeny-based identification of EVs, clinical isolates from patients with AHC were subjected to the analysis. It has been reported that AHC is caused primarily by 2 EVs, CV-A24v and EV-70. These viruses are indistinguishable clinically. We used 19 isolates of CV-A24v and 14 isolates of EV-70, all obtained from large outbreaks in different parts of the world. These CV-A24v and EV-70 isolates, especially 3C pro and VP1, are well characterized genetically [23, 24] and therefore are extremely useful for evaluating the reliability of phylogeny-based identification of EVs.
When VP4 nucleotide sequences of the 19 isolates of CVA24v were compared with those of the 66 prototype strains, all isolates showed 86.0%-99.5% nucleotide identity with the prototype strain of CV-A24v (EH24/70). The next highest homologies between isolate and prototype strains were 79.2%-87.0% (table 2) . Thus, 4.8%-13.1% differences were observed between homologous and heterologous prototype strains, allowing us to identify the isolates of CV-A24v. When the 14 EV-70 isolates were analyzed, a similar result was obtained. All had the highest identity with the prototype strain EV-70. At least a 15.4% difference was seen between EV-70 and the next highest nucleotide identity (with EV-68; table 2). Therefore, the phylogenetic analyses based on VP4 successfully separated 19 CV-A24v strains and 14 EV-70 strains into distinct monophyletic clusters with their respective prototype strains. All CV-A24v isolates were segre- Figure 3 . Phylogenetic analyses of clinical isolates from patients with aseptic meningitis, herpangina, or hand, foot, and mouth disease. Isolates serologically identified as CV-A2, CV-A4-CV-A8, CV-A10, CV-A16, and EV-71 (A); CV-A9, E-5, E-6, E-16, E-18, E-21, E-24, E-30, CV-B3, and CV-B4 (B); and CV-A21 and PV-1-PV-3 (C). Results were obtained by neighbor-joining methods; prototype strains (*). Nos. at nodes are percentage of 1000 bootstrap pseudoreplicates containing the cluster distal to the node. CV, coxsackievirus; E, echovirus; EV, enterovirus; PV, poliovirus. gated into cluster C along with the prototype with 89% bootstrap support ( figure 2A) , and all EV-70 strains were separated into cluster D along with the prototype with 100% bootstrap support ( figure 2B ). These results show that phylogeny-based clustering with VP4 nucleotide sequences allows for identification of clinical isolates from patients with AHC.
Amplification and identification of aseptic meningitis, HFMD, and herpangina clinical isolates. We applied this method to the rapid diagnosis of aseptic meningitis, HFMD, and herpangina, major diseases caused by EVs afflicting children over the last 30 years. The nucleotide sequences from 43 isolates of 18 serotypes, in which the serotype was determined by an ordinary neutralization test, were analyzed with 13 sequences of 8 serotypes from GenBank. These serotypes were 1 each of CV-A6-CV-A8, CV-A21, CV-B4, E-8, E-21, E-24, and PV-1; 2 each of CV-A9, CV-A10, CV-B3, E-5, E-6, E-16, and PV-2; 3 each of CA-A2, CV-A4, and E-18; 4 each of CV-A5 and PV3; 5 each of CV-A16 and EV-71; and 6 of E-30.
When the VP4 nucleotide sequences of these isolates were compared with those of the 66 prototype strains, each isolate showed the highest nucleotide identity with its respective prototype: 76.8%-80.2%, CV-A2; 85.5%-89.4%, CV-A4; 77.8%-85.0%, CV-A5; 83.1%, CV-A6; 81.6%, CV-A7; 83.6%, CV-A8; 81.6%-82.1%, CV-A9; 80.7%-85.5%, CV-A10; 79.7%-82.1%, CV-A16; 96.1%, CV-A21; 96.1%-99.5%, CV-B3; 98.6%, CV-B4; 87.9%-90.3%, E-5; 89.9%-98.6%, E-6; 94.2%, E-8; 83.1%-85.0%, E-16; 75.8%-77.3%, E-18; 92.3%, E-21; 91.3%, E-24; 83.6%-87.4%, E-30; 81.6%-83.6%, EV-71; 99.5%, PV-1; 87.0%-87.4%, PV-2; and 88.4%-99.5%, PV-3. Except for 3 E-18 isolates, all isolates showed at least 2.4% higher identity with the homologous prototype strain than with the highest heterologous strains (table 3) . The E-18 isolates Mie/2/88, Tokyo/7286/98, and Tokyo/7363/98 showed 75.8%-77.3% nucleotide identity with their prototype Metcalf strain, which was first reported in 1958 in Ohio [1] . Although only 0.4%-0.5% nucleotide differences were seen when the isolates were compared with the E-18 prototype (75.8%-77.3%) and highest scoring heterologous prototypes CV-B1, E-6, E-8, and E-29 prototype strains (75.4%-76.8%) (table 3), these heterologous prototype strains showed 3.4%-11.1% higher identities with other prototype strains than with these E-18 isolates (data not shown). Therefore, E-18 isolates cannot be grouped in a serotype other than E-18.
These 3 Japanese E-18 isolates showed a 90.8% nucleotide identity with each other. Although 3 E-18 isolates and the prototype Metcalf strain formed distinct clusters in cluster B (with 79% bootstrap support), they formed an even more distinct cluster (with 100% bootstrap support; figure 3B ). Twenty-five isolates of 9 serotypes, CV-A2, CV-A4-CV-A8, CV-A10, CV-A16, and EV-71, were segregated into cluster A with their prototype strains; Fleetwood, High Point, Swartz, Gdula, Parker, Donovan, Kowalik, G-10, and BrCr ( figure 3A) . In contrast, 23 isolates of 11 serotypes, CV-A9, CV-B3, CV-B4, E-5, E-6, E-8, E-16, E-18, E-21, E-24, and E-30, and their prototype strains, Bozek, Nancy, JVB, Noyce, D'Amori, Bryson, Harrington, Metcalf, Farina, DeCamp, and Bastianni, were grouped in cluster B ( figure 3B ). These isolates, except for 2 E-16 isolates, formed distinct clusters with their respective prototype strains. Although these 2 E-16 isolates and the prototype strain Harrington formed 1 cluster with 65% bootstrap support, the E-16 isolates showed 4.8%-5.3% higher identities with the homologous prototype strain than with the highest heterogenous strain, E-31. The CV-A21 isolates formed a distinct cluster C with their prototype strain, Kuykendall. The wild strain of poliovirus and Mahoney, Lansing, Leon, and each type of Sabin strain were grouped into poliovirus and formed distinct clusters ( figure 3C ). These results demonstrate that the primer set was significantly useful: 66 prototype strains and 76 isolates from 20 serotypes were efficiently amplified. The phylogenetic clustering of EVs on the basis of VP4 nucleotide sequences is a powerful tool for the identification of most EV isolates.
Discussion
With the development of molecular-biologic techniques, the means of classifying and identifying EVs changed from serologic assays to genetic analyses. Most studies have used RT-PCR and targeted the 5 0 NTR, followed by nucleotide sequencing, because this region encodes an array of conserved sequences across the EV genome, which makes it easier to design primers. Although many RT-PCR strategies rapidly detect all EVs in the genome, they are not capable of classifying EVs correctly. For example, comparison of the 5 0 NTR nucleotide sequences from GenBank resulted in classifying all EVs into only 2 groups (i.e., poliovirus, CV-A 21, CV-A24v, and EV-70 in 1 cluster and CV-B, CV-A9, CV-A16, EV-71, E-11, and E-12 in another) [25] [26] [27] [28] because the nucleotide sequences of each amplified fragment did not diverge sufficiently to allow the strains to be segregated into their own species.
The recent completion of VP1 nucleotide sequences (834-951 bp) in all EV prototypes suggests that the genetic classification of VP1 correlates strongly with the reclassification approved by the 7th ICTV [12, 29] . The VP4 nucleotide sequences may be less sensitive than VP1 sequences in detecting segregation of EVs into distinct subgroups within the cluster, probably because VP1 contains a number of neutralization epitopes and because its nucleotide sequence is mostly diverged in the genome [1] . Indeed, serologically diagnosed clinical isolates have been genotyped successfully with partial VP1 sequences [13, 14, 30] . However, genotyping has been achieved in only 22 prototypes, presumably because of higher divergence in the primer sequences among serotypes and the narrow specificity of the primers. At least 5 primer sets are essential to VP1 amplification of untypeable EVs [13] , and a few isolates are refractory to amplification [30] . Recently, a newly designed primer set in VP1 and VP2 was used to amplify all prototype strains [14] . This single set of primers was capable of amplifying 59 prototype strains but also failed to amplify 5 prototype strains, including CV-A5, CV-A19, and CV-A22, which thrive only in suckling mice, and 2 members of distant human EV-D species, EV-68 and EV-70 [14] .
In contrast, the primers described in this study not only amplified all prototype strains but also 76 recent clinical isolates of 20 serotypes from patients with aseptic meningitis, HFMD, herpangina, and AHC that were obtained from different areas over .30 years (table 3) . We also amplified 34 clinical isolates of 16 serotypes, including wild strains of poliovirus (PV-1-PV-3), CV-A3, CV-B1-CV-B6, E-8, E-9, E-11 E-12, E-17, and E-25 (data not shown). Therefore, it is likely that these primer sequences were also conserved among recent EV isolates.
By our method, we could diagnose human EV infections within a few days, in contrast with the 2-4 weeks or longer that an ordinary neutralization test requires. Therefore, this phylogeny-based system is highly useful when a rapid diagnosis is required, such as during an outbreak of fatal encephalitis. This method revealed that E-7 (not EV-71) caused severe and fatal encephalitis during the 2000 outbreak of HFMD in Malaysia (P. McMinn, personal communication). The method is also useful in evaluating the attribution of EVs to various infectious diseases and to a suspected viral disease such as insulin-dependent diabetes mellitus. RT-PCR is capable of directly amplifying enteroviral RNA from a clinical sample, and phylogenetic analysis based on VP4 can classify the EV. Indeed, we recently demonstrated that low numbers of CV-A in human EV A, which are usually difficult to isolate from cell cultures, are associated with febrile seizures in the summer season [31] .
EVs, like other RNA viruses, have a high mutation rate because of the lack of proofreading activity during genome replication. It is estimated that 1 mutation is generated per newly synthesized genome [32] and that EVs have a mutation rate 1 million times higher than that of the human genome [33] .
We previously reported that CV-A24v collected in the Eastern Hemisphere over nearly 2 decades (1970-1989) diverged, accumulating mutations (substitutions) in the genome at a rate of 3:7 £ 10 ÿ3 nt/year [23, 34] . Similarly, the mutation rate of EV-70 isolates collected worldwide, including those from 2 pandemic periods in 1971 and 1981, are estimated to be 3:8 £ 10 ÿ3 nt/year [24] . The higher mutation rate of EVs makes it difficult to identify clinical isolates by a neutralization test, particularly when the mutation occurs in antigenic epitopes [35] [36] [37] . However, this higher mutation rate is advantageous for phylogeny-based classification because it enables detailed molecular epidemiologic studies even when a relatively short region of the genome (207 bp of complete VP4) is used. The VP4 nucleotide sequences were sufficiently diverged to segregate the isolates from heterologous serotypes. For example, although the nucleotide identity between CV-A24v/Singapore/1/75 and CV-A24v/ Beijing1/88 (figure 2A), isolated 13 years apart, was 84.1%, these 2 isolates were classified in CV-A24v. The reliability of phylogenetic analysis based on the VP4 nucleotide sequences appears to be satisfactory, because CV-A24v isolates were segregated into the same chronologic clusters as those based on 3C pro nucleotides [23] . We recently applied VP4 nucleotide sequences to the molecular epidemiology of EV-71 in Taiwan [38] .
In conclusion, we have developed a new, rapid, and simple method of identifying human EVs based on phylogenetic analysis of VP4. RT-PCR that used a set of primers was efficient in amplifying all prototype strains. This method takes advantage of the divergence in relatively short VP4 sequences both within and between serotypes, enabling us to rapidly identify 89 isolates from 26 serotypes that appeared .30 years apart. Our method, in conjunction with accumulation of database nucleotide sequences, should be of use not only for the rapid diagnosis of human EVs but also for global epidemiologic studies of these viruses.
